[Hong Kong, 4 March 2016] Hong Kong Applied Science and Technology Research Institute Company Limited (ASTRI) has announced the appointment of Mr Andy Liu, Vice Chairman of Hong Kong Biotechnology Organization, to the ASTRI Board for a term of two years with effect from 1 March 2016.
Mr Andy Liu has served as President of Asia Pacific and China for IMS Health, a TPG private equity portfolio company focusing on big data healthcare. Mr Liu’s area of focus is commercialisation and M&A. He has extensive experience in healthcare big data and healthcare technologies.
Furthermore, commencing 1 March 2016, three serving Directors of ASTRI, namely Mr Cheng Cheuk-wing, Prof Ching Pak-chung and Mr Ha Yung-kuen have also been re-appointed for another two-year term.
Related News
![ASTRI Establishes the ConTech and PropTech Alliance Driving I&T Adoption for Boosting Efficiency, Quality and Safety](https://www.astri.org/wp-content/uploads/2024/07/1-1024x652.jpg)
![ASTRI Showcases Advanced 5G and V2X Smart Mobility Technologies at MWC Shanghai 2024](https://www.astri.org/wp-content/uploads/2024/06/GroupPhoto-1024x768.jpeg)
![ASTRI Summer Internship Programmes Commence Today Offering 110 Elite University Students R&D Experience in Hong Kong](https://www.astri.org/wp-content/uploads/2024/06/1-1-1024x683.jpg)
![ASTRI partners with Immigration Department Provide top quality and efficient services through innovative technologies](https://www.astri.org/wp-content/uploads/2024/04/Photo-1-2-1024x683.jpg)
![ASTRI’s Wins 23 Awards Geneva Inventions Expo Gemstones Identification Technology Earns Gold Medal with Congratulations of Jury](https://www.astri.org/wp-content/uploads/2024/04/Photo-1-1024x682.jpeg)